Complete Response After Imatinib Mesylate Therapy in a Patient With Well-Differentiated Systemic Mastocytosis-Reference-Cited by-同舟云学术

Complete Response After Imatinib Mesylate Therapy in a Patient With Well-Differentiated Systemic Mastocytosis

Published:2012-04-20 Issue:12 Volume:30 Page:e126-e129
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Álvarez-Twose Iván¹,González Pablo²,Morgado José Mário¹,Jara-Acevedo María³,Sánchez-Muñoz Laura¹,Matito Almudena¹,Mollejo Manuela⁴,Orfao Alberto³,Escribano Luis¹

Affiliation:

1. Instituto de Estudios de Mastocitosis de Castilla La Mancha, Hospital Virgen del Valle, Toledo, Spain

2. Hospital Virgen de las Nieves, Granada, Spain

3. Centro de Investigación del Cáncer, Universidad de Salamanca, Salamanca, Spain

4. Hospital Virgen del Valle, Toledo, Spain

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/JCO.2011.38.9973

Reference35 articles.

1. Classes of c-KIT activating mutations: proposed mechanisms of action and implications for disease classification and therapy

2. Imatinib for systemic mast-cell disease

3. Effects of tyrosine kinase inhibitor STI571 on human mast cells bearing wild-type or mutated c-kit

4. Imatinib mesylate in the treatment of systemic mastocytosis

5. Advanced mast cell disease: an Italian Hematological Multicenter experience

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent Advances in the Therapeutic Management of Advanced Systemic Mastocytosis;Diagnostics;2023-12-29

2. Mastocytosis demystified;Hematology;2023-12-08

3. Targeted therapy for advanced forms of systemic mastocytosis in real clinical practice;Oncohematology;2023-12-07

4. Management of Advanced Systemic Mastocytosis and Associated Myeloid Neoplasms;Immunology and Allergy Clinics of North America;2023-11

5. KIT Inhibitors for the Treatment of Advanced Systemic Mastocytosis: Focus on the Elderly Patients;INT J GERONTOL;2023